Back to
FMR LLC
KRYSShowing 8 of 28 quarters
Position history for
FMR LLC's holdings in KRYSTAL BIOTECH INC
Yes. FMR holds 4,418,197 shares of KRYS (Krystal Biotech), worth $1.6B, as of its Q2 2026 13F filing. It increased the position by 44,210 shares (+1.0%) from Q1 2026. FMR has held KRYS in every 13F on record since Q3 2019, 28 quarterly filings. KRYS is 0.1% of FMR's reported 13F portfolio.
Current Value
$1.6B
Current Shares
4.4M
Total Value Change
+$860.7M
Total Shares Change
+125,316
Quarter-by-Quarter History
Other major holders of KRYS: BlackRock, Inc., Avoro Capital Advisors LLC